October 2, 2018 | 10.00 AM
The outbreak of the COVID-19 pandemic has led to a sudden shift in the dynamics of consumer behavior.
September 25, 2020
Stress Management for Oncology Healthcare Professionals During COVID-19
Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.
Read now September 25, 2020
Stress Management for Oncology Healthcare Professionals During COVID-19
Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.
Read now September 25, 2020
Stress Management for Oncology Healthcare Professionals During COVID-19
Objective: To communicate simple tips of self-care and stress management with HCPs during COVID-19 pandemic.
Read nowLatest News
October 2, 2018 | 10.00 AM
Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…
October 2, 2018 | 10.00 AM
Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…
October 2, 2018 | 10.00 AM
Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…
October 2, 2018 | 10.00 AM
Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…
October 2, 2018 | 10.00 AM
Dr. Reddy's Laboratories announces the launch of AVIGAN® (Favipiravir) for COVID-19…
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Managing Myelodysplastic Syndromes Patients During COVID-19 Pandemic
Objective: To communicate interim guidelines to safely manage myelodysplastic.
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate simple tips to HCP’s for delivering optimal care during COVID-19 pandemic.
September 25, 2020
Objective: To communicate change in prophylaxis guidelines for cancer patients during COVID pandemic
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate interim guidelines to safely manage hematologic malignancies
September 25, 2020
Objective: To communicate simple tips to HCP’s for delivering optimal care during COVID-19 pandemic.
September 25, 2020
Objective: To communicate change in prophylaxis guidelines for cancer patients during COVID pandemic